David J. Matly, M.B.A.
Equibles does not estimate personal net worth.
Get an email with a short summary when Inhibrx Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.
Get INBX alertsAbout David J. Matly, M.B.A.
Inhibrx Biosciences, Inc. reported in an 8-K filed April 1, 2025 that David J. Matly, M.B.A. was appointed President, effective April 1, 2025. Inhibrx Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Inhibrx Biosciences, Inc. includes Mark P. Lappe (CEO and Board Member), Kelly D. Deck (CFO), Douglas G. Forsyth (Board Member) and 3 others.
“On April 1, 2025, Inhibrx Biosciences, Inc. (the "Company") announced the appointment of David J. Matly, M.B.A. as President, effective April 1, 2025, adding to his current role as Chief Commercial and Business Development Officer.”
Affiliation history
-
Inhibrx Biosciences, Inc. (INBX)
SEC 8-K
Current2025-04-01–present
Company network
Leadership on record at Inhibrx Biosciences, Inc.
- Mark P. Lappe CEO, Board Member
- Kelly D. Deck CFO
- Douglas G. Forsyth Board Member
- Jon Faiz Kayyem Board Member
- Kimberly Manhard Board Member
- Kristiina Vuori Board Member